239 related articles for article (PubMed ID: 12470283)
1. History and evolution of the pharmacophore concept in computer-aided drug design.
Güner OF
Curr Top Med Chem; 2002 Dec; 2(12):1321-32. PubMed ID: 12470283
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore modeling in drug discovery and development: an overview.
Khedkar SA; Malde AK; Coutinho EC; Srivastava S
Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
[TBL] [Abstract][Full Text] [Related]
3. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
Tropsha A; Zheng W
Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
[TBL] [Abstract][Full Text] [Related]
4. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
Wolber G; Seidel T; Bendix F; Langer T
Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
[TBL] [Abstract][Full Text] [Related]
5. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
6. The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design.
Seidel T; Schuetz DA; Garon A; Langer T
Prog Chem Org Nat Prod; 2019; 110():99-141. PubMed ID: 31621012
[TBL] [Abstract][Full Text] [Related]
7. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.
Dror O; Shulman-Peleg A; Nussinov R; Wolfson HJ
Curr Med Chem; 2004 Jan; 11(1):71-90. PubMed ID: 14754427
[TBL] [Abstract][Full Text] [Related]
8. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
Singh K; Bhushan B; Singh B
Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
Acharya C; Coop A; Polli JE; Mackerell AD
Curr Comput Aided Drug Des; 2011 Mar; 7(1):10-22. PubMed ID: 20807187
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Descriptor Spaces for QSAR: Delving into the History of the Expanding Frontier.
Basak SC; Mishra RK
Curr Comput Aided Drug Des; 2017; 13(1):4-7. PubMed ID: 28222673
[No Abstract] [Full Text] [Related]
11. Pharmacophore discovery--lessons learned.
van Drie JH
Curr Pharm Des; 2003; 9(20):1649-64. PubMed ID: 12871063
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.
Kapetanovic IM
Chem Biol Interact; 2008 Jan; 171(2):165-76. PubMed ID: 17229415
[TBL] [Abstract][Full Text] [Related]
13. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.
Dixon SL; Smondyrev AM; Knoll EH; Rao SN; Shaw DE; Friesner RA
J Comput Aided Mol Des; 2006; 20(10-11):647-71. PubMed ID: 17124629
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
Gupta GK; Kumar A
Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
[TBL] [Abstract][Full Text] [Related]
15. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
16. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.
Ekins S; Mestres J; Testa B
Br J Pharmacol; 2007 Sep; 152(1):9-20. PubMed ID: 17549047
[TBL] [Abstract][Full Text] [Related]
17. A novel integrated framework and improved methodology of computer-aided drug design.
Chen CY
Curr Top Med Chem; 2013; 13(9):965-88. PubMed ID: 23651478
[TBL] [Abstract][Full Text] [Related]
18. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
19. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
20. Obituary: Toshio Fujita, QSAR pioneer.
Akamatsu M; Oprea TI
J Comput Aided Mol Des; 2017 Nov; 31(11):959-960. PubMed ID: 29119351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
